🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
10.65
+0.24 (2.31%)
At close: Nov 19, 2026, 4:00 PM EST
10.66
+0.01 (0.09%)
After-hours: Nov 19, 2026, 4:10 PM EST

Eloxx Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
56.264.790.111.1319.2142.27
Cash & Short-Term Investments
56.264.790.111.1319.2142.27
Cash Growth
-4210.81%-90.21%-94.10%-54.56%71.35%
Accounts Receivable
--2.36---
Other Receivables
--0.36---
Receivables
--2.72---
Prepaid Expenses
1.990.140.070.150.090.12
Restricted Cash
0.010.010.010.220.260.3
Other Current Assets
-0.340.080.050.570.79
Total Current Assets
58.265.272.981.5520.1343.48
Property, Plant & Equipment
---0.160.991.66
Total Assets
58.265.272.981.7121.1245.14

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.422.715.355.73.021.38
Accrued Expenses
2.831.6521.212.84.2
Short-Term Debt
11.8411.8213.3512.9712.543.72
Current Portion of Long-Term Debt
-16.522.223.98-
Current Portion of Leases
--00.130.710.66
Other Current Liabilities
0.1-0.10.470.05-
Total Current Liabilities
17.1917.1827.3122.723.099.96
Long-Term Debt
---1.618.5612
Long-Term Leases
---00.140.8
Total Liabilities
17.1917.1827.3124.3131.7822.76

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.040.050.040.030.020.02
Additional Paid-In Capital
355.41288.63270.22268.81263.71262.88
Retained Earnings
-314.38-300.58-294.59-291.44-274.39-238.32
Treasury Stock
------2.19
Total Common Equity
41.07-11.91-24.34-22.6-10.6622.38
Shareholders' Equity
41.07-11.91-24.34-22.6-10.6622.38
Total Liabilities & Equity
58.265.272.981.7121.1245.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.8412.8219.8716.9325.9217.18
Net Cash (Debt)
44.43-8.03-19.76-15.8-6.7125.09
Net Cash Growth
-----112.14%
Net Cash Per Share
6.88-7.15-57.82-67.60-34.08157.78
Filing Date Shares Outstanding
4.090.460.340.230.20.2
Total Common Shares Outstanding
4.090.440.340.230.20.2
Working Capital
41.07-11.91-24.34-21.15-2.9633.53
Book Value Per Share
10.05-27.34-71.22-96.70-54.13113.66
Tangible Book Value
41.07-11.91-24.34-22.6-10.6622.38
Tangible Book Value Per Share
10.05-27.34-71.22-96.70-54.13113.66
Machinery
---0.260.290.28
Construction In Progress
-----0.02
Leasehold Improvements
---0.060.060.09